Staley Capital Advisers Inc. Sells 399 Shares of Merck & Co., Inc. (NYSE:MRK)

Staley Capital Advisers Inc. reduced its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 4.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,167 shares of the company’s stock after selling 399 shares during the period. Staley Capital Advisers Inc.’s […]

Related Keywords

Steven Mizell ,Joseph Romanelli ,Animal Health ,Wealthspire Advisors ,Securities Exchange Commission ,Peddock Capital Advisors ,Merck Co Inc ,Wells Fargo Company ,Richardp Slaughter Associates Inc ,Merck Co ,Truwealth Advisors ,Quarter For Merck Co Inc ,Cantor Fitzgerald ,Staley Capital Advisers Inc ,News Ratings For Merck Co ,Staley Capital Advisers ,Free Report ,Capital Advisers ,Capital Advisors ,Wealth Advisors ,Exchange Commission ,Truist Financial ,Trading Down ,Get Free Report ,Nyse Mrk ,Mrk ,Medical ,58933y10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,